Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Study finds low-risk of spillover SARS-CoV-2 infection from domestic cats

Study finds low-risk of spillover SARS-CoV-2 infection from domestic cats

One year after severe COVID-19, T cells persist against SARS-CoV-2

One year after severe COVID-19, T cells persist against SARS-CoV-2

Virtual reality helps reduce COVID-19 vaccine hesitancy

Virtual reality helps reduce COVID-19 vaccine hesitancy

Fourth COVID-19 vaccine dose substantially reduces mortality in the elderly

Fourth COVID-19 vaccine dose substantially reduces mortality in the elderly

Natural SARS-CoV-2 antibodies persist for six months in children

Natural SARS-CoV-2 antibodies persist for six months in children

Hybrid immunity and booster vaccination provides best protection against SARS-CoV-2 BA.1 and BA.2

Hybrid immunity and booster vaccination provides best protection against SARS-CoV-2 BA.1 and BA.2

Risk of death from SARS-CoV-2 infection higher than after COVID vaccination

Risk of death from SARS-CoV-2 infection higher than after COVID vaccination

Evaluating severity of influenza infection in ferrets with COVID-19 history

Evaluating severity of influenza infection in ferrets with COVID-19 history

Examining differences in neurological manifestations induced by SARS-CoV-2 variants in hamsters

Examining differences in neurological manifestations induced by SARS-CoV-2 variants in hamsters

Dynamics of SARS-CoV-2 viral load in vaccinated and recovered individuals

Dynamics of SARS-CoV-2 viral load in vaccinated and recovered individuals

Study investigates room-temperature stable, self-amplifying RNA vaccine against SARS-CoV-2

Study investigates room-temperature stable, self-amplifying RNA vaccine against SARS-CoV-2

The potential risk of SARS-CoV-2 transmission through fomites contaminated by hospitalized COVID-19 patients

The potential risk of SARS-CoV-2 transmission through fomites contaminated by hospitalized COVID-19 patients

Durability and functionality of the humoral and T-cell response to SARS-CoV-2 and its variants in recovered patients

Durability and functionality of the humoral and T-cell response to SARS-CoV-2 and its variants in recovered patients

Study investigates recombinant SARS-CoV-2 variants in immunocompromised individuals

Study investigates recombinant SARS-CoV-2 variants in immunocompromised individuals

Study estimates protection against reinfection following primary SARS-CoV-2 infection

Study estimates protection against reinfection following primary SARS-CoV-2 infection

Benefits of heterotypic vaccination against variants of SARS-CoV-2

Benefits of heterotypic vaccination against variants of SARS-CoV-2

Mathematical model of SARS-CoV-2 transmission tailored to the unique situation of China

Mathematical model of SARS-CoV-2 transmission tailored to the unique situation of China

Study evaluates receptor-binding domain antibodies for their ability to bind and neutralize Omicron

Study evaluates receptor-binding domain antibodies for their ability to bind and neutralize Omicron

Severe outcomes in hospitalized children during the Omicron BA.2-dominated fifth wave in Hong Kong

Severe outcomes in hospitalized children during the Omicron BA.2-dominated fifth wave in Hong Kong

Which U.S. cities are most vulnerable to spread of COVID-19?

Which U.S. cities are most vulnerable to spread of COVID-19?

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.